Posterior Nasal Neurectomy for Eosinophilic Chronic Rhinosinusitis With Allergic Rhinitis: Efficacy Study
- 23 May 2025
- journal article
- Published by Wiley in The Laryngoscope
- Vol. 135 (11) , 4099-4106
Abstract
Objective: To evaluate the efficacy of posterior nasal neurectomy (PNN) in patients with eosinophilic chronic rhinosinusitis (eCRS) and moderate to severe persistent allergic rhinitis (AR). Methods: A total of 42 patients with eCRS and AR were recruited from the Otorhinolaryngology Department of Qingdao University Affiliated Hospital between December 1, 2022, and January 1, 2024. All patients underwent functional endoscopic sinus surgery (FESS), with 20 receiving additional PNN (intervention group) and 22 undergoing FESS alone (control group). Subjective symptoms were assessed using the visual analog scale (VAS), sino‐nasal outcome test‐22 (SNOT‐22), and rhinoconjunctivitis quality of life questionnaire (RQLQ). Objective assessments included the modified Lund‐Kennedy endoscopic score and Lund‐Mackay CT score. Postoperative nasal secretions were collected for cytokine analysis using enzyme‐linked immunosorbent assay (ELISA). Results: Preoperatively, the intervention group exhibited higher rates of excessive sneezing and emotional impact on RQLQ scores ( p < 0.05). At 6‐month follow‐up, the intervention group showed significantly reduced subjective symptom scores (SNOT‐22, p = 0.003; RQLQ activity, p < 0.001; nasal symptoms, p = 0.003; eye symptoms, p = 0.002; total RQLQ score, p = 0.007) and improved objective symptoms (Lund‐Kennedy score, p < 0.001) compared to the control group. Greater reductions (Δ) were observed in eye symptoms ( p = 0.002), emotional ( p = 0.002), and Modified Lund‐Kennedy score ( p < 0.001). Postoperative IL‐5 concentrations were lower in the intervention group ( p = 0.023). Conclusions: Concurrent PNN with FESS is both safe and effective, leading to significant improvements in both subjective and objective symptoms in eCRS patients with AR. Cytokine analysis further supports the therapeutic benefits of this combined approach. Level of Evidence: 3.Keywords
Funding Information
- National Natural Science Foundation of China (82471140)
- Natural Science Foundation of Shandong Province (ZR2023MH027)
- Natural Science Foundation of Qingdao Municipality (23‐2‐1‐199‐zyyd‐jch)
This publication has 20 references indexed in Scilit:
- Advances in co-pathogenesis of the united airway diseasesRespiratory Medicine, 2024
- Endoscopic vidian and vidian‐branch neurectomy for refractory allergic rhinitis: A systematic reviewInternational Forum of Allergy & Rhinology, 2023
- The anatomy of the foramina and efferent nerve fibers from the pterygopalatine ganglion in posterolateral nasal wallLaryngoscope Investigative Otolaryngology, 2022
- The long-term outcomes of posterior nasal neurectomy with or without pharyngeal neurectomy in patients with allergic rhinitis: a randomized controlled trialBrazilian Journal of Otorhinolaryngology, 2021
- Effect of posterior nasal neurectomy on the suppression of allergic rhinitisAmerican Journal of Otolaryngology, 2020
- International Consensus Statement on Allergy and Rhinology: Allergic RhinitisInternational Forum of Allergy & Rhinology, 2018
- Endoscopic vidian neurectomy: a prospective case seriesInternational Forum of Allergy & Rhinology, 2015
- Endoscopic transsphenoidal vidian neurectomyEuropean Archives of Oto-Rhino-Laryngology, 2011
- Submucous turbinectomy combined with posterior nasal neurectomy in the management of severe allergic rhinitis: Clinical outcomes and local cytokine changesAuris Nasus Larynx, 2007
- Histamine release from nasal mucosal mast cells in patients with chronic hypertrophic non-allergic rhinitis, after parasympathetic nerve stimulationInflammation Research, 1988